Cargando…
Receptor-Defined Breast Cancer in Five East African Countries and Its Implications for Treatment: Systematic Review and Meta-Analysis
PURPOSE: Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) are determinants of treatment and mortality for patients with breast cancer (BC). In East Africa, the estimated 5-year survival (37.7%) is far lower than the US average (90%). This meta-a...
Autores principales: | Popli, Pallvi, Gutterman, Elane M., Omene, Coral, Ganesan, Shridar, Mills, Douglas, Marlink, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081496/ https://www.ncbi.nlm.nih.gov/pubmed/33591798 http://dx.doi.org/10.1200/GO.20.00398 |
Ejemplares similares
-
Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer
por: George, Mridula A., et al.
Publicado: (2021) -
Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker
por: Qureshi, Sadaf, et al.
Publicado: (2022) -
Equality in Maternal and Newborn Health: Modelling Geographic Disparities in Utilisation of Care in Five East African Countries
por: Ruktanonchai, Corrine W., et al.
Publicado: (2016) -
Correction: Equality in Maternal and Newborn Health: Modelling Geographic Disparities in Utilisation of Care in Five East African Countries
por: Ruktanonchai, Corrine W., et al.
Publicado: (2016) -
Estimating the impact of birth interval on under-five mortality in east african countries: a propensity score matching analysis
por: Tesema, Getayeneh Antehunegn, et al.
Publicado: (2023)